Dolomite collaborates with European technology leaders to develop cutting …News-Medical.netDanish project partners OptoRobotix (R&D performing SME) and Bioneer (technological service partner) and Dolomite will jointly develop a cutting edge stem cell handling technology. As the market leader in microfluidic design, Dolomite will exploit its … …read more &nbs… Continue reading
Athersys Treatment for Stem Cell Transplant Complication Gets Orphan Status in …Wall Street JournalThe biotechnology company said the designation complements the U.S. orphan drug status it received for its MultiStem therapy for patients at risk of developing graft-versus-host disease following hemoatopoietic stem cell transplants, which can be …Athersys’ MultiStem(R) Stem Cell Therapy Receives Orphan Drug … Continue reading
Research and Markets: Global Stem Cell Market Report 2013Vancouver SunHowever, recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ injuries, including cardiovascular disease, neurological disease, musculoskeletal disease, diabetes and … …read more &nbs… Continue reading
Pluristem and Korea’s CHA in $10.4m stem cell collaborationGlobesStem cell developer Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) and Korea’s CHA Bio&Diostech (Kodaq: CHA) are pushing forward with the strategic partnership agreement reached in June. The two companies have concluded a mutual …Pluristem Therapeutics Inc. : Pluristem and CHA Move Forward on Strategic …4-traders (press … Continue reading
Stem cell research uncovers importance of cell cycleMedical Xpress(Medical Xpress)—One of the biggest problems in stem cell research may not be a problem at all. Scientists have worried for years that stem cells grown in their labs were made up of many different kinds of cells, making them useless for stem cell …Complete 2012-13 Induced … Continue reading
Stem Cell Therapeutics Appoints Dr. Robert Kirkman to Its Board of DirectorsMarketWatchTORONTO, ONTARIO, Dec 17, 2013 (Marketwired via COMTEX) — Stem Cell Therapeutics Corp. (CVE:CA:SSS) (otcqx:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announced that industry veteran Dr. and more …read more &nbs… Continue reading
Athersys’ MultiStem(R) Stem Cell Therapy Receives Orphan Drug Designation in …NASDAQThe Company is developing its MultiStem cell therapy as a GvHD prophylaxis in patients undergoing allogeneic hematopoietic stem cell (HSC) transplant and is currently preparing for a Phase II/III clinical study in the area. The MultiStem therapy for …Athersys Treatment for Stem Cell Transplant Complication … Continue reading
Doctors inject stem cells into foetus to treat brittle bone diseaseStraits TimesBabies diagnosed with brittle bone disease can now be treated before they are born, thanks to a new stem cell treatment. The treatment involves injecting stem cells that aid in bone formation into the foetus. This procedure was performed on a girl by a … Continue reading